The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects

BACKGROUND: The new STHLM3 test, combining protein markers, genetic markers, and clinical data to assess a man’s prostate cancer (PCa) risk, has been investigated in Sweden within the frame of the STHLM3 trial. OBJECTIVE: To assess whether the STHLM3 test influences men’s worry level, PCa knowledge,...

Descripción completa

Detalles Bibliográficos
Autores principales: Koitsalu, Marie, Eklund, Martin, Adolfsson, Jan, Sprangers, Mirjam A.G., Grönberg, Henrik, Brandberg, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317863/
https://www.ncbi.nlm.nih.gov/pubmed/34337495
http://dx.doi.org/10.1016/j.euros.2020.12.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317863/
https://www.ncbi.nlm.nih.gov/pubmed/34337495
http://dx.doi.org/10.1016/j.euros.2020.12.010

Ejemplares similares